{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:33:03Z","timestamp":1781094783790,"version":"3.54.1"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"State Key Program of Basic Research of China","award":["2015CB910304"],"award-info":[{"award-number":["2015CB910304"]}]},{"DOI":"10.13039\/501100018537","name":"National Science & Technology Major Project","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013279","name":"Key New Drug Creation and Manufacturing Program","doi-asserted-by":"publisher","award":["2018ZX09711002-001-003"],"award-info":[{"award-number":["2018ZX09711002-001-003"]}],"id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDA12020372"],"award-info":[{"award-number":["XDA12020372"]}]},{"name":"Tencent AI Lab Rhino-Bird Focused Research Program","award":["JR202002"],"award-info":[{"award-number":["JR202002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Motivation<\/jats:title>\n                  <jats:p>Breast cancer is one of the leading causes of cancer deaths among women worldwide. It is necessary to develop new breast cancer drugs because of the shortcomings of existing therapies. The traditional discovery process is time-consuming and expensive. Repositioning of clinically approved drugs has emerged as a novel approach for breast cancer therapy. However, serendipitous or experiential repurposing cannot be used as a routine method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In this study, we proposed a graph neural network model GraphRepur based on GraphSAGE for drug repurposing against breast cancer. GraphRepur integrated two major classes of computational methods, drug network-based and drug signature-based. The differentially expressed genes of disease, drug-exposure gene expression data and the drug\u2013drug links information were collected. By extracting the drug signatures and topological structure information contained in the drug relationships, GraphRepur can predict new drugs for breast cancer, outperforming previous state-of-the-art approaches and some classic machine learning methods. The high-ranked drugs have indeed been reported as new uses for breast cancer treatment recently.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Availabilityand implementation<\/jats:title>\n                  <jats:p>The source code of our model and datasets are available at: https:\/\/github.com\/cckamy\/GraphRepur and https:\/\/figshare.com\/articles\/software\/GraphRepur_Breast_Cancer_Drug_Repurposing\/14220050.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Supplementary information<\/jats:title>\n                  <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btab191","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T12:10:47Z","timestamp":1616069447000},"page":"2930-2937","source":"Crossref","is-referenced-by-count":50,"title":["Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug\u2013drug links based on graph neural network"],"prefix":"10.1093","volume":"37","author":[{"given":"Chen","family":"Cui","sequence":"first","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Ding","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifan","family":"Chen","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Xiao","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyang","family":"Xu","sequence":"additional","affiliation":[{"name":"Tencent AI Lab , Shenzhen 518057, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3323-3092","authenticated-orcid":false,"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0426-3417","authenticated-orcid":false,"given":"Xiaomin","family":"Luo","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualiang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"},{"name":"School of Life Science and Technology, ShanghaiTech University , Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixian","family":"Chen","sequence":"additional","affiliation":[{"name":"Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences , Shanghai 201203, China"},{"name":"University of Chinese Academy of Sciences , Beijing 100049, China"},{"name":"School of Life Science and Technology, ShanghaiTech University , Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,19]]},"reference":[{"key":"2023061310561066200_btab191-B1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s10495-016-1288-4","article-title":"Mycophenolic acid potentiates HER2-overexpressing SKBR3 breast cancer cell line to induce apoptosis: involvement of AKT\/FOXO1 and JAK2\/STAT3 pathways","volume":"21","author":"Aghazadeh","year":"2016","journal-title":"Apoptosis Int. J. Programmed Cell Death"},{"key":"2023061310561066200_btab191-B2","doi-asserted-by":"crossref","first-page":"105615","DOI":"10.1016\/j.biocel.2019.105615","article-title":"Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)","volume":"116","author":"Alipour","year":"2019","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"2023061310561066200_btab191-B3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrcardio.2016.101","article-title":"Precision medicine in cardiology","volume":"13","author":"Antman","year":"2016","journal-title":"Nat. Rev. Cardiol"},{"key":"2023061310561066200_btab191-B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrd3375","article-title":"Trial watch: phase III and submission failures: 2007-2010","volume":"10","author":"Arrowsmith","year":"2011","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023061310561066200_btab191-B5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin"},{"key":"2023061310561066200_btab191-B6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn"},{"key":"2023061310561066200_btab191-B7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1039\/c3mb70490d","article-title":"A hybrid method for prediction and repositioning of drug anatomical therapeutic chemical classes","volume":"10","author":"Chen","year":"2014","journal-title":"Mol. Biosyst"},{"key":"2023061310561066200_btab191-B8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jbi.2015.09.016","article-title":"Prediction of drug's Anatomical Therapeutic Chemical (ATC) code by integrating drug-domain network","volume":"58","author":"Chen","year":"2015","journal-title":"J. Biomed. Inform"},{"key":"2023061310561066200_btab191-B9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/jamia\/ocw007","article-title":"A network-based drug repositioning infrastructure for precision cancer medicine through targeting significantly mutated genes in the human cancer genomes","volume":"23","author":"Cheng","year":"2016","journal-title":"J. Am. Med. Inf. Assoc. JAMIA"},{"key":"2023061310561066200_btab191-B10","first-page":"682","article-title":"Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era","volume":"18","author":"Cheng","year":"2017","journal-title":"Brief. Bioinf"},{"key":"2023061310561066200_btab191-B11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/bioinformatics\/btw644","article-title":"iATC-mISF: a multi-label classifier for predicting the classes of anatomical therapeutic chemicals","volume":"33","author":"Cheng","year":"2017","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B12","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41467-019-10744-6","article-title":"A genome-wide positioning systems network algorithm for in silico drug repurposing","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun"},{"key":"2023061310561066200_btab191-B13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00994018","article-title":"Support-vector networks","volume":"20","author":"Cortes","year":"1995","journal-title":"Mach. Learn"},{"key":"2023061310561066200_btab191-B14","doi-asserted-by":"crossref","first-page":"e12819","DOI":"10.1111\/acel.12819","article-title":"Gene expression-based drug repurposing to target aging","volume":"17","author":"Donertas","year":"2018","journal-title":"Aging Cell"},{"key":"2023061310561066200_btab191-B15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd.2017.226","article-title":"Drug development in the era of precision medicine","volume":"17","author":"Dugger","year":"2018","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023061310561066200_btab191-B16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1940-6207.CAPR-19-0315","article-title":"Effect of bazedoxifene and conjugated estrogen (Duavee) on breast cancer risk biomarkers in high-risk women: a pilot study","volume":"12","author":"Fabian","year":"2019","journal-title":"Cancer Prev. Res. (PA)"},{"key":"2023061310561066200_btab191-B17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: a gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann. Stat"},{"key":"2023061310561066200_btab191-B18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/msb.2011.26","article-title":"PREDICT: a method for inferring novel drug indications with application to personalized medicine","volume":"7","author":"Gottlieb","year":"2011","journal-title":"Mol. Syst. Biol"},{"key":"2023061310561066200_btab191-B19","first-page":"1025","volume-title":"Proceedings of the 31st International Conference on Neural Information Processing Systems","author":"Hamilton","year":"2017"},{"key":"2023061310561066200_btab191-B20","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P","article-title":"Proteomics of breast cancer for marker discovery and signal pathway profiling","volume":"1","author":"Hondermarck","year":"2001","journal-title":"Proteomics"},{"key":"2023061310561066200_btab191-B21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"2023061310561066200_btab191-B22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1021\/ci500670q","article-title":"Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data","volume":"55","author":"Iwata","year":"2015","journal-title":"J. Chem. Inf. Model"},{"key":"2023061310561066200_btab191-B23","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1074\/jbc.M115.679704","article-title":"Dimethyl fumarate inhibits the nuclear factor B pathway in breast cancer cells by covalent modification of p65 protein","volume":"291","author":"Kastrati","year":"2016","journal-title":"J. Biol. Chem"},{"key":"2023061310561066200_btab191-B24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nbt1284","article-title":"Relating protein pharmacology by ligand chemistry","volume":"25","author":"Keiser","year":"2007","journal-title":"Nat. Biotechnol"},{"key":"2023061310561066200_btab191-B25","author":"Kipf","year":"2017"},{"key":"2023061310561066200_btab191-B26","first-page":"4899","article-title":"Sunitinib inhibits breast cancer cell proliferation by inducing apoptosis, cell-cycle arrest and DNA repair while inhibiting NF-kappaB signaling pathways","volume":"37","author":"Korashy","year":"2017","journal-title":"Anticancer Res"},{"key":"2023061310561066200_btab191-B27","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.acthis.2014.09.010","article-title":"Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model","volume":"116","author":"Kubatka","year":"2014","journal-title":"Acta Histochem"},{"key":"2023061310561066200_btab191-B28","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"2023061310561066200_btab191-B29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","journal-title":"Nature"},{"key":"2023061310561066200_btab191-B30","first-page":"2999","author":"Lin","year":"2017"},{"key":"2023061310561066200_btab191-B31","doi-asserted-by":"crossref","first-page":"e1007701","DOI":"10.1371\/journal.pcbi.1007701","article-title":"Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes","volume":"16","author":"Liu","year":"2020","journal-title":"PLoS Comput. Biol"},{"key":"2023061310561066200_btab191-B32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12859-016-1336-7","article-title":"Inferring new indications for approved drugs via random walk on drug\u2013disease heterogenous networks","volume":"17","author":"Liu","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"2023061310561066200_btab191-B33","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/bioinformatics\/btw228","article-title":"Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm","volume":"32","author":"Luo","year":"2016","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B34","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/bioinformatics\/bty013","article-title":"Computational drug repositioning using low-rank matrix approximation and randomized algorithms","volume":"34","author":"Luo","year":"2018","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B35","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1039\/C8SC00148K","article-title":"Large-scale comparison of machine learning methods for drug target prediction on ChEMBL","volume":"9","author":"Mayr","year":"2018","journal-title":"Chem. Sci"},{"key":"2023061310561066200_btab191-B36","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: a promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"2023061310561066200_btab191-B37","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res"},{"key":"2023061310561066200_btab191-B38","author":"Petar Veli\u010dkovi\u0107","year":"2017"},{"key":"2023061310561066200_btab191-B39","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/bioinformatics\/bty133","article-title":"A novel computational approach for drug repurposing using systems biology","volume":"34","author":"Peyvandipour","year":"2018","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.drudis.2018.11.022","article-title":"The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions","volume":"24","author":"Polamreddy","year":"2019","journal-title":"Drug Discov. Today"},{"key":"2023061310561066200_btab191-B41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fphar.2017.00896","article-title":"Enhancing the promise of drug repositioning through genetics","volume":"8","author":"Pritchard","year":"2017","journal-title":"Front. Pharmacol"},{"key":"2023061310561066200_btab191-B42","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1073\/pnas.1320001111","article-title":"Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus","volume":"111","author":"Reker","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023061310561066200_btab191-B43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.placenta.2016.09.019","article-title":"Etravirine inhibits ABCG2 drug transporter and affects transplacental passage of tenofovir disoproxil fumarate","volume":"47","author":"Reznicek","year":"2016","journal-title":"Placenta"},{"key":"2023061310561066200_btab191-B44","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/bioinformatics\/btz156","article-title":"A new computational drug repurposing method using established disease-drug pair knowledge","volume":"35","author":"Saberian","year":"2019","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B45","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1634\/theoncologist.2019-0231","article-title":"A phase II trial of selinexor (KPT-330) for metastatic triple-negative breast cancer","volume":"24","author":"Shafique","year":"2019","journal-title":"Oncologist"},{"key":"2023061310561066200_btab191-B46","doi-asserted-by":"crossref","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and preclinical validation of drug indications using compendia of public gene expression data","volume":"3","author":"Sirota","year":"2011","journal-title":"Sci. Transl. Med"},{"key":"2023061310561066200_btab191-B47","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L 1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"2023061310561066200_btab191-B48","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein\u2013protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2023061310561066200_btab191-B49","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1158\/0008-5472.CAN-15-3490","article-title":"Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors","volume":"77","author":"Valenti","year":"2017","journal-title":"Cancer Res"},{"key":"2023061310561066200_btab191-B50","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41416-020-0743-8","article-title":"Ibrutinib treatment inhibits breast cancer progression and metastasis by inducing conversion of myeloid-derived suppressor cells to dendritic cells","volume":"122","author":"Varikuti","year":"2020","journal-title":"Br. J. Cancer"},{"key":"2023061310561066200_btab191-B51","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: a review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"2023061310561066200_btab191-B52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/bioinformatics\/bty543","article-title":"NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug\u2013target interactions","volume":"35","author":"Wan","year":"2019","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B53","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/bioinformatics\/btu403","article-title":"Drug repositioning by integrating target information through a heterogeneous network model","volume":"30","author":"Wang","year":"2014","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B54","doi-asserted-by":"crossref","first-page":"i525","DOI":"10.1093\/bioinformatics\/btaa437","article-title":"Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing","volume":"36","author":"Wang","year":"2020","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B55","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2023061310561066200_btab191-B56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mbs.2018.09.010","article-title":"A similarity-based method for prediction of drug side effects with heterogeneous information","volume":"306","author":"Xian","year":"2018","journal-title":"Math. Biosci"},{"key":"2023061310561066200_btab191-B57","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1093\/bioinformatics\/btz182","article-title":"Drug repositioning through integration of prior knowledge and projections of drugs and diseases","volume":"35","author":"Xuan","year":"2019","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B58","doi-asserted-by":"crossref","first-page":"I455","DOI":"10.1093\/bioinformatics\/btz331","article-title":"Drug repositioning based on bounded nuclear norm regularization","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B59","doi-asserted-by":"crossref","first-page":"e1007541","DOI":"10.1371\/journal.pcbi.1007541","article-title":"Overlap matrix completion for predicting drug-associated indications","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Comput. Biol"},{"key":"2023061310561066200_btab191-B60","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1755-8794-8-S2-S2","article-title":"Inferring drug\u2013disease associations based on known protein complexes","volume":"8","author":"Yu","year":"2015","journal-title":"BMC Med. Genomics"},{"key":"2023061310561066200_btab191-B61","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1093\/bioinformatics\/btz418","article-title":"deepDR: a network-based deep learning approach to in silico drug repositioning","volume":"35","author":"Zeng","year":"2019","journal-title":"Bioinformatics"},{"key":"2023061310561066200_btab191-B62","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1574893614666190220114644","article-title":"Predicting drug side effects with compact integration of heterogeneous networks","volume":"14","author":"Zhao","year":"2019","journal-title":"Curr. Bioinform"},{"key":"2023061310561066200_btab191-B63","first-page":"2610","article-title":"iATC-NRAKEL: an efficient multi-label classifier for recognizing anatomical therapeutic chemical (ATC) classes of drugs","volume":"33","author":"Zhou","year":"2019","journal-title":"Bioinformatics"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bioinformatics\/advance-article-pdf\/doi\/10.1093\/bioinformatics\/btab191\/37939810\/btab191.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/18\/2930\/50579169\/btab191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/37\/18\/2930\/50579169\/btab191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T10:58:44Z","timestamp":1686653924000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/37\/18\/2930\/6178784"}},"subtitle":[],"editor":[{"given":"Anthony","family":"Mathelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":63,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btab191","relation":{},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,15]]},"published":{"date-parts":[[2021,3,19]]}}}